However, this medicine is intended to help people with certain health conditions lose weight, such as type 2 diabetes patients and those who are obese or overweight
That short window is why meal timing, protein density, and fiber quality matter for postprandial incretin signaling
The authors note that semaglutide had a holistic therapeutic approach to both liver disease and associated cardiometabolic illnesses. These results lend further credence that semaglutide is the Swiss army knife of medicine we have been looking for, to treat obesity, cardiovascular disease, type 2 diabetes, and now MASH, Beverly Tchang, MD, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine, not affiliated with the trial, told Healthline.
Since these are not necessarily visible they can be frustrating, however these are the building blocks to long-term success and ensuring that GLP-1 supplementation is working